ANNE MCVAY: Open Payments
NPI 1952006389 · MAYFLOWER, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 27 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $822 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $214 |
| ABBVIE INC. | 7 | $131 |
| Novo Nordisk Inc | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, FANAPT, Rybelsus, Kerendia, VOQUEZNA, AUSTEDO XR, Wegovy.
Industry payments across AR — which companies pay providers there.
